Prescription ·Strong evidence ·Reviewed May 2026
Estradiol is the primary and most potent endogenous estrogen, used in hormone replacement therapy (HRT) for menopausal symptoms including vasomotor symptoms (hot flashes), vulvovaginal atrophy, and osteoporosis prevention. Transdermal and oral formulations are available. The Women's Health Initiative (WHI) reshaped prescribing practices. Current guidelines favor the lowest effective dose for the shortest duration, with transdermal delivery preferred for reduced thrombotic risk.
The bottom line
Evidence rating strong. Most-documented uses: effective relief of vasomotor symptoms (hot flashes, night sweats), treatment of vulvovaginal atrophy and urogenital symptoms, prevention of postmenopausal osteoporosis. 10 sources indexed (2015–2025), with 4 interaction records on file.
Core mechanism
Binds to estrogen receptors (ER-alpha and ER-beta) in target tissues including the hypothalamus, uterus, breast, bone, cardiovascular system, and brain. The estrogen-receptor complex modulates gene transcription, maintaining reproductive tissue integrity, promoting bone density by inhibiting osteoclast activity, supporting vasomotor stability through hypothalamic thermoregulatory centers, and regulating lipid metabolism. Also has non-genomic rapid signaling effects on vascular endothelium.6,8
Oral: can be taken with or without food. Transdermal: apply to clean, dry skin of lower abdomen or buttock; rotate sites. Topical gel: apply to arm or thigh as directed.5
St. John's Wort induces CYP3A4, which metabolizes estradiol. This can reduce estradiol levels by 20-40%, potentially causing breakthrough bleeding, hot flashes, or loss of menopausal symptom control.
Recommendation: Avoid St. John's Wort while on estradiol HRT. Breakthrough bleeding and return of menopausal symptoms may occur.
DIM shifts estrogen metabolism toward 2-hydroxy metabolites (less potent), potentially reducing estradiol's effectiveness for menopausal symptom control.
Recommendation: If using DIM with estradiol HRT, monitor symptom control. DIM may reduce estradiol effectiveness. Discuss with your prescriber.
Black cohosh (Cimicifuga racemosa) is used for menopausal symptoms and has mild estrogenic and serotonergic activity. Combining it with prescribed estradiol is rarely necessary and complicates side-effect attribution, including for rare liver-injury cases reported with black cohosh.
Recommendation: If you are already on prescribed estradiol for menopausal symptoms, adding black cohosh is generally not needed. If you decide to combine them, do so under clinician supervision and watch for jaundice, dark urine, or abdominal pain (signs of liver injury). Stop and seek care if these occur.
Maca has been used for menopausal symptoms and sexual function with modest positive findings in small trials, and does not contain phytoestrogens. It is generally compatible with prescribed estradiol but is rarely needed and may complicate side-effect attribution.
Recommendation: If menopausal symptoms persist on prescribed estradiol, maca 1.5-3 g/day may be tried with prescriber awareness. Maca does not raise serum estradiol, so dose adjustments are usually not needed.
Numbered references. Citations throughout the page link here.
Winston-McPherson GN, Thomas TA, Krasowski MD et al.. Estradiol Concentrations for Adequate Gender-Affirming Feminizing Therapy: A Systematic Review. LGBT health. 2025
Gulamhusein N, Miranda KT, Ahmed SB et al.. Measurements of Postmenopausal Serum Estradiol Levels and Cardiovascular Events: A Systematic Review. CJC open. 2024
Comini ACM, Carvalho BM, Moreira MJB et al.. Safety and Serum Estradiol Levels in Hormonal Treatments for Vulvovaginal Atrophy in Breast Cancer Survivors: A Systematic Review and Meta-Analysis. Clinical breast cancer. 2023
Wang Y, Wang H, Cai J et al.. Association Between Estradiol and Human Aggression: A Systematic Review and Meta-Analysis. Psychosomatic medicine. 2023
Corbelli J, Shaikh N, Wessel C et al.. Low-dose transdermal estradiol for vasomotor symptoms: a systematic review. Menopause (New York, N.Y.). 2015
Graham S, Archer DF, Simon JA et al.. Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2022
Syed YY. Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids. Drugs. 2022
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack